Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colo; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo.
Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colo.
Acad Pediatr. 2018 Sep-Oct;18(7):754-762. doi: 10.1016/j.acap.2018.03.007. Epub 2018 Mar 28.
Some parents are concerned the childhood immunization schedule could increase risk for allergic disorders, including asthma. To inform future safety studies of this speculated association, a parent survey was conducted to examine the risk of misclassification of vaccination status in electronic health record data, and to assess the potential for confounding if asthma risk factors varied by vaccination status.
A survey was conducted among parents of children 19 to 35 months old at 6 medical organizations within the Vaccine Safety Datalink. Parents of children in 4 vaccination groups were surveyed: 1) no vaccines by 12 months of age and a diagnosis of parental vaccine refusal; 2) consistent vaccine limiting (≤2 vaccines per visit); 3) not consistently vaccine limiting but otherwise undervaccinated with a vaccine refusal diagnosis; and 4) fully vaccinated with no delays and no vaccine refusal. Parents were surveyed about their child's vaccination status and whether asthma risk factors existed.
Among a survey sample of 2043 parents, 1209 responded (59.2%). For receiving no vaccines, the observed agreement between parent report and electronic health record data was 94.0% (κ = 0.79); for receiving all vaccines with no delays, the observed agreement was 87.3% (κ = 0.73). Although most asthma risk factors (allergic rhinitis, eczema, food allergies, family asthma history) reported by parents did not differ significantly between children in the vaccination groups studied, several factors (aeroallergen sensitivity, breastfeeding) differed significantly between groups.
Measurement and control of disease risk factors should be carefully considered in observational studies of the safety of the immunization schedule.
一些家长担心儿童免疫接种计划会增加过敏疾病(包括哮喘)的风险。为了为未来对这种推测关联的安全性研究提供信息,我们进行了一项家长调查,以检查电子健康记录数据中疫苗接种状况错误分类的风险,并评估如果哮喘危险因素因接种状况而异,是否存在混杂的可能性。
在疫苗安全数据链中的 6 个医疗组织中,对 19 至 35 个月大的儿童的家长进行了一项调查。对以下 4 个疫苗接种组的儿童的家长进行了调查:1)12 个月龄前未接种疫苗且有家长拒绝接种疫苗的诊断;2)持续限制疫苗接种(每次就诊≤2 剂);3)未持续限制疫苗接种但因其他原因未充分接种疫苗且有疫苗拒绝诊断;4)完全接种疫苗且无延迟且无疫苗拒绝。家长接受了有关其子女疫苗接种状况和是否存在哮喘危险因素的调查。
在一项针对 2043 名家长的调查样本中,有 1209 名家长(59.2%)做出了回应。对于未接种疫苗,家长报告与电子健康记录数据之间的观察一致性为 94.0%(κ=0.79);对于所有疫苗均无延迟且无疫苗拒绝的儿童,观察一致性为 87.3%(κ=0.73)。尽管父母报告的大多数哮喘危险因素(过敏性鼻炎、湿疹、食物过敏、家族哮喘史)在研究的疫苗接种组儿童中没有显著差异,但一些因素(气传过敏原敏感性、母乳喂养)在组间存在显著差异。
在免疫接种计划安全性的观察性研究中,应仔细考虑疾病危险因素的测量和控制。